Tetraphase Pharmaceuticals
About:
Tetraphase Pharmaceuticals is a company leveraging a dynamic drug engine targeted at several significant disease categories.
Website: http://tphase.com
Twitter/X: tetraphase
Top Investors: F-Prime Capital, Excel Venture Management, Fidelity Ventures, CARB-X, CMEA Capital
Description:
Capitalizing on breakthrough synthetic chemistry, Tetraphase Pharmaceuticals is leveraging a dynamic drug engine targeted at several significant disease categories.
Total Funding Amount:
$99M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Watertown, Massachusetts, United States
Founded Date:
2006-01-01
Founders:
Lawrence G. Miller, Paul A. Howard
Number of Employees:
51-100
Last Funding Date:
2017-04-01
IPO Status:
Public
Industries:
© 2025 bioDAO.ai